You are here: Industry Insights > DRDO

News List

BDR Pharmaceuticals announces license agreement with DRDO to manufacture 2-DG drug in India expresspharma
July 27, 2021
BDR Pharma has signed a license agreement with the Defence Research and Development Establishment (DRDE) and the Institute of Nuclear Medicine and Allied Sciences (INMAS) of the Defence Research and Development Organisation (DRDO) for the ...
BHL gets license from Defence Research and Development Organisation (DRDO) to manufacture and market “2-Deoxy-D-Glucose” (2-DG), used in control & treatment of Covid-19. firstwordpharma
July 09, 2021
Bajaj Healthcare Limited (BHL) a leading manufacturer of APIs, Intermediates and Formulations, has received a licence from DRDO to Manufacture and Market of “2-Deoxy-D-Glucose” (2-DG) as approved medication for the treatment of COVID-19 patients.
Mankind Pharma gets DRDO nod to make and market 2-DG expresspharma
July 09, 2021
The company will manufacture the product at its facilities in Visakhapatnam and Himachal Pradesh.
Laurus Labs gets DRDO nod to make and market 2-Deoxy-D-glucose (2DG) in India expresspharma
July 05, 2021
Laurus Labs announced that it has received the licence from Defence Research & Development Organisation (DRDO) to manufacture and market of 2-Deoxy-D-Glucose (2DG).
Dr Reddy’s Laboratories commercially launches 2DG expresspharma
June 29, 2021
The maximum retail price (MRP) of each sachet has been fixed at Rs 990, with a subsidised rate offered to government institutions.
DRDO launches anti-COVID drug 2-DG expresspharma
May 18, 2021
The first batch of DRDO-developed anti-COVID drug 2-DG (2-deoxy-D-glucose) has been launched to treat patients suffering from the deadly COVID-19. The medicine comes in powder form and can be taken with water.
Procurement norms for ministries of health and pharma, DRDO relaxed expresspharma
May 12, 2021
The Department of Expenditure has allowed global tenders to be floated for less than Rs 200 crore as well.
DCGI nod for anti-COVID 19 drug developed by DRDO expresspharma
May 10, 2021
Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.